Human amniotic membrane modulates collagen production and deposition in vitro

• Published in: Scientific reports 2024-07, Vol.14 (1), p.15998-13, Article 15998
• Main Authors: Moreno, Sarah E., Enwerem-Lackland, Isioma, Dreaden, Kristiana, Massee, Michelle, Koob, Thomas J., Harper, John R.
• Format: Article
• Language: English
• Subjects: 631/80/304; 639/301/54/994; Allografts; Amnion; Amnion - metabolism; Amniotic membrane; Biosynthesis; Cell Differentiation; Chorion; Chorion - metabolism; Collagen; Collagen (type I); Collagen - metabolism; Collagen Type I - genetics; Collagen Type I - metabolism; Extracellular matrix; Extracellular Matrix - metabolism; Female; Fibrosis; Humanities and Social Sciences; Humans; Macromolecules; Membranes; multidisciplinary; Myofibroblasts - metabolism; Science; Science (multidisciplinary); Transforming Growth Factor beta1 - metabolism; Transforming growth factor-b1
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-64364-2

Pathological fibrosis is a significant complication of surgical procedures resulting from the accumulation of excess collagen at the site of repair which can compromise the tissue architecture and severely impede the function of the affected tissue. Few prophylactic treatments exist to counteract this process; however, the use of amniotic membrane allografts has demonstrated promising clinical outcomes. This study aimed to identify the underlying mechanism of action by utilizing relevant models that accurately represent the pathophysiology of the disease state. This study employed a pro-fibrotic in vitro system using TGFβ1 stimulation and macromolecular crowding techniques to evaluate the mechanism by which amniotic membrane allografts regulate collagen biosynthesis and deposition. Following treatment with dehydrated human amnion chorion membrane (DHACM), subsequent RNA sequencing and functional enrichment with Reactome pathway analysis indicated that amniotic membranes are indeed capable of regulating genes associated with the composition and function of the extracellular matrix. Furthermore, macromolecular crowding was used in vitro to expand the evaluation to include both the effects of DHACM and a lyophilized human amnion/chorion membrane (LHACM). DHACM and LHACM regulate the TGFβ pathway and myofibroblast differentiation. Additionally, both DHACM and LHACM modulate the production, secretion, and deposition of collagen type I, a primary target for pathological fibrosis. These observations support the hypothesis that amniotic membranes may interrupt pathological fibrosis by regulating collagen biosynthesis and associated pathways.